Oncology Ventures
Oncology Ventures is a New York-based seed-stage venture capital firm founded by Ben Freeberg, a cancer survivor, in 2022-2023. The firm is dedicated to investing in data-driven startups that aim to improve non-drug cancer care. Its mission is to enhance the U.S. oncology system by addressing its inefficiencies and barriers. The firm focuses on healthcare data, AI, IT, and infrastructure startups that facilitate early detection, patient navigation, and treatment optimization. Oncology Ventures typically invests between $250,000 and $1.5 million in seed and early-stage companies. It has closed
Investing activity
Oncology Ventures appears in 2 AI deals tracked by the AI Lounge deals desk, and led 1 of them. The rounds are mostly Seed, with a median round size of $6M. The most recent are Modicus Prime (Seed, $4.5M, May 2026) and Health Universe (Seed, $6M, Mar 2026).
Oncology Ventures most often invests alongside Frist Cressey Ventures, Silverton Partners, Twelve Below and Kleiner Perkins, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Oncology Ventures
What AI companies has Oncology Ventures invested in?
Oncology Ventures's AI investments include Modicus Prime and Health Universe. The 2 rounds on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Oncology Ventures based?
Oncology Ventures is based in Tempe, Arizona, United States.
What stage does Oncology Ventures invest at?
In the rounds tracked on AI Lounge, Oncology Ventures has invested at Seed, with a median round of $6M. Oncology Ventures led 1 of those rounds.
Who does Oncology Ventures co-invest with?
Oncology Ventures's most frequent co-investors on AI Lounge are Frist Cressey Ventures (1 deal), Silverton Partners (1 deal), Twelve Below (1 deal) and Kleiner Perkins (1 deal).
How can founders reach Oncology Ventures?
Founders on AI Lounge can see Oncology Ventures's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Oncology Ventures to their Investor Pipeline to track the conversation.